Zidovudine
CAS No. 30516-87-1
Zidovudine( Azidothymidine | AZT | ZDV )
Catalog No. M13969 CAS No. 30516-87-1
A nucleoside reverse transcriptase inhibitor (NRTI) that used to prevent and treat HIV/AIDS.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 40 | In Stock |
|
| 100MG | 52 | In Stock |
|
| 200MG | 68 | In Stock |
|
| 500MG | 117 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameZidovudine
-
NoteResearch use only, not for human use.
-
Brief DescriptionA nucleoside reverse transcriptase inhibitor (NRTI) that used to prevent and treat HIV/AIDS.
-
DescriptionA nucleoside reverse transcriptase inhibitor (NRTI) that used to prevent and treat HIV/AIDS.HIV Infection Approved.
-
In Vitro——
-
In Vivo——
-
SynonymsAzidothymidine | AZT | ZDV
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorReverseTranscriptase|Telomerasereversetranscriptase
-
Research AreaInfection
-
IndicationHIV Infection
Chemical Information
-
CAS Number30516-87-1
-
Formula Weight267.2413
-
Molecular FormulaC10H13N5O4
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 2.7 mg/mL
-
SMILESO=C1NC(C(C)=CN1[C@@H]2O[C@H](CO)[C@@H](N=[N+]=[N-])C2)=O
-
Chemical NameThymidine, 3'-azido-3'-deoxy-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
DAPTA
DAPTA is a synthetic peptide, functions as a viral entry inhibitor by targeting selectively CCR5, and shows potent anti-HIV activities. DAPTA potently inhibits specific CD4-dependent binding of gp120 Bal (IC50 = 0.06 nM) and CM235 (IC50 = 0.32 nM) to CCR5.
-
SCH 351125
A small molecule inhibitor of HIV-1 entry via the CCR5 coreceptor.
-
DPC-681
A potent and selective inhibitor of HIV-1 protease with IC90 of 4-40 nM.
Cart
sales@molnova.com